Perspective Therapeutics (CATX) Preferred Shares Issued (2013 - 2014)
Perspective Therapeutics recorded quarterly Preferred Shares Issued of -$9.0 in Q1 2014, up 98.75% quarter-over-quarter from -$719.0 in Q4 2013.
Perspective Therapeutics' Preferred Shares Issued history runs 2 years deep, the most recent figure standing at -$9.0 for Q1 2014.
- In Q1 2014, Preferred Shares Issued changed N/A year-over-year to -$9.0; the TTM figure through Jun 2014 stood at $1.5 million (changed N/A YoY), while the FY2014 annual figure was $1.5 million, changed N/A from the prior year.
- Preferred Shares Issued came in at -$9.0 for Q1 2014 at Perspective Therapeutics, up from -$719.0 in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $1.5 million in Q3 2013 to a low of -$719.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | -9.00 |
| Mar 31, 2014 | -9.00 |
| Dec 31, 2013 | -719.00 |
| Dec 31, 2013 | -719.00 |
| Sep 30, 2013 | 1.48 Mn |
| Sep 30, 2013 | 1.48 Mn |